Researchers at Glasgow University find parents and caregivers of people with Dravet Syndrome need better support.

Ultimately, Stoke Therapeutics is that classic “intriguing biotech” --hurdling to one of those proverbial “moments of truth” ...

Glasgow mum Marie McLeish has a child with Dravet Syndrome - a rare and severe form of epilepsy. Her daughter Amanda, 35, ...

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing ...

Dravet Syndrome occurs in around one in every 15,000 live births and is among the most treatment-resistant genetic epilepsies.

Neurvati Neurosciences, a clinical-stage biotechnology company dedicated to bringing a new generation of therapies to people affected by neurological and psychiatric disorders, and GRIN Therapeutics, ...

CBD oil's popularity surges across wellness and pharmaceutical sectors, lauded for potential benefits like pain and anxiety ...

Paige Figi — mom to Charlotte Figi, the child whose story captivated the nation as CBD helped her seizure disorder — tells ...

Paige Figi once came under fire for the medical decisions she made as a mom. Now, she tells PEOPLE about blocking out the ...

Biogen has bolstered its pipeline by licensing ex-US rights to a drug for Dravet syndrome – a rare form of epilepsy – from Stoke Therapeutics in a deal that included an upfront payment of $165 ...

Extreme temperatures have a serious impact on the health and daily lives of those with conditions such as epilepsy, multiple ...